Tender detail

Non-exclusive rebate agreements for ranibizumab medicines under an open-house model

Summary

The procurement concerns non-exclusive rebate agreements for medicines containing ranibizumab as a 10 mg/ml injection solution in a vial (ATC code S01LA04). Agreements are concluded through an open-house model, with no supply exclusivity; quantities are unknown and no minimum purchase volume is guaranteed. The agreements end no later than 31 December 2027.

Reference number
6ea5562d-5c4d-4934-a8bd-c170c511b76d
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2027-12-31
Status
Open
Contract subject
Supplies
Estimated value
Not published
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.